Media-OutReach Newswire Etiqa offers new short-term endowment plan with attractive 2.10% p.a. returns upon maturity
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 5.